Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.
Journal: Scientific reports
Published: November 05, 2022
Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.
Journal: Scientific reports
Published: April 26, 2022
Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 05, 2022
Gut microbiome and pancreatic cancer cachexia: An evolving relationship.
Journal: World journal of gastrointestinal oncology
Published: March 03, 2022
Advances in Pancreatic Ductal Adenocarcinoma Treatment.
Journal: Cancers
Published: September 17, 2021
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer.
Journal: Journal of gastrointestinal oncology
Published: August 29, 2018
Showing 1-6 of 6
Last Updated: 09/26/2026